Pediatric Oncology Treatment Market: Overview

Childhood cancer is a term used to describe cancer that occurs between birth and 15 years of age. Pediatric cancer is quite rare and may differ from adult cancers in the way they grow. Several cancer treatments are currently available. The type of cancer and stage determine the treatment. The primary cause of childhood cancer is not known; however, researchers assume that 5% of all cancers in children is caused by an inherited mutation. The Children’s Oncology Group (COG) is the world’s largest organization that conducts clinical research to improve the care and treatment of children with cancer. 

Pediatric Oncology Treatment Market: Key Trends

Rise in prevalence of cancer, favorable reimbursement scenario, and health care reforms are the major factors that boost the global pediatric oncology treatment market. According to WHO data (2018), cancer is a leading cause of death among children and adolescents across the world; nearly 300,000 children aged between 0 and 19 are diagnosed with cancer each year. Moreover, in 2018, the WHO launched the Global Initiative for Childhood Cancers with various partners to provide proper childhood cancer programs across the world. 

Pediatric Oncology Treatment Market: Segmentation

The global pediatric oncology treatment market can be segmented based on indication, treatment, end-user, and region. In terms of indication, the market can be classified into leukemia, bone tumors, brain cancers, retinoblastoma, lymphoma, and others. Leukemia accounts for majority of all pediatric cancers. The segment is projected to dominate the market during the forecast period, as it is the most common childhood cancer. Based on treatment, the global pediatric oncology treatment market can be categorized into chemotherapy, radiotherapy, tumor surgery, and blood & marrow transplantation. The chemotherapy segment is anticipated to account for significant share of the market during the forecast period. Drugs used in chemotherapy can effectively destroy cancer cells. This factor drives the segment. In terms of end-user, the market can be divided into hospitals, specialty clinics, and cancer & radiation therapy centers. The hospitals segment is expected to expand at a high CAGR during the forecast period owing to high patient preference for these settings for cancer treatment. 

Pediatric Oncology Treatment Market: Regional Analysis

In terms of region, the global pediatric oncology treatment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2018. The region is projected to account for significant share of the global market due to well-defined reimbursement policies from public and private health insurance firms which helps patients to avail surgery and other treatment options. According to the National Cancer Institute, in early 2019, around 11,000 new cases of childhood cancer were diagnosed in the U.S. An estimated 6,000 childhood cancer patients succumb to the disease in Europe each year. Asia Pacific is expected to account for significant share of the market in terms of revenue during the forecast period due to rise in awareness about the different treatment options for pediatric. 

Pediatric Oncology Treatment Market: Competitive Landscape

Major players operating in the global pediatric oncology treatment market include Royal Children’s Hospital, St. Jude Children’s Research Hospitals, Birmingham Women’s and Children’s, the National Center for Child Health and Development, the Vanderbilt University Medical Center, St. Louis Children’s Hospitals, and SSM Health.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

.